google-site-verification: googlec7193c3de77668c9.html

Monoclonal antibody shows promising results for rare liver disease

[
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and anti-fibrotic monoclonal antibody known as nebokitug was safe and showed potential efficacy in patients with PSC.


Source link

Advertisements
Views: 0

See also  Australia wildfire rips through homes

Check Also

Early Alzheimer’s patients pursuing lecanemab show low adherence to brain health advice

[ Researchers at the Mass General Brigham Neuroscience Institute found that most patients with early …

New study finds bacterial infections affect about 1 in 20 hospitalized adults with firearm injuries

[ Credit: Unsplash/CC0 Public Domain A new study by researchers at the University of Maryland …

Dense breasts or breast cancer in the family? What screening changes mean for you

[ The way women are screened for breast cancer in Australia is changing. According to …

Leave a Reply

Available for Amazon Prime
Elfbar elfa prefilled pod watermelon nikotinfrei. elfbar elfa kit.